Abstract:
Positive opinion supported by superior efficacy shown in two head-to-head phase III trials, including overall survival in DREAMM-7.
Select a country to view results for that country.
Published: 23 May 2025 by GSK press release
Abstract:
Positive opinion supported by superior efficacy shown in two head-to-head phase III trials, including overall survival in DREAMM-7.
Copyright © Therapists Africa 2025